Yazan Madanat, MD (@madanatyazan) 's Twitter Profile
Yazan Madanat, MD

@madanatyazan

Associate Professor. Leukemia Director @UTSWcancer. Chief Hem/Onc Fel ‘19, IM Res ‘16 @ClevelandClinic. Cure #CMML #AML #MDS Tweets = my own

ID: 735280130302574592

linkhttps://www.utsouthwestern.edu/simmons/ calendar_today25-05-2016 01:23:38

1,1K Tweet

1,1K Followers

905 Following

Maximilian Stahl (@maxstahlmd) 's Twitter Profile Photo

🗽Join me in NYC this summer to explore the most controversial clinical issues in the field of hematologic malignancies! Network with local experts and bring best practices back to your clinic. Register for free using my last name as a discount code: shorturl.at/Cdsdf

OncLive.com (@onclive) 's Twitter Profile Photo

Hear Courtney DiNardo, MD, MSCE, of MD Anderson Cancer Center Rami komrokji, of Moffitt Cancer Center and Amer Zeidan MBBS,MHS ‏عامر زيدان of Yale School of Medicine discuss primary therapeutic goals for patients with intermediate- to high-risk myelodysplastic syndromes. Watch the full video here: hubs.li/Q03lp2fy0

Yazan Madanat, MD (@madanatyazan) 's Twitter Profile Photo

Beautiful day in #Rotterdam Visit Netherlands for the MDS Foundation Meeting #2025 — honored to be here in this stunning city. Great opening by G Garcia-Manero on #HR-MDS and an exciting agenda ahead. Looking forward to an inspiring few days! #MDS25 MDS Foundation UTSW Simmons Cancer Center

Beautiful day in #Rotterdam <a href="/Visit_NL/">Visit Netherlands</a> for the MDS Foundation Meeting #2025 — honored to be here in this stunning city. Great opening by <a href="/garciamanero/">G Garcia-Manero</a> on #HR-MDS and an exciting agenda ahead. Looking forward to an inspiring few days! #MDS25 <a href="/MDSFoundation/">MDS Foundation</a> <a href="/utswcancer/">UTSW Simmons Cancer Center</a>
Amer Zeidan MBBS,MHS ‏عامر زيدان (@dr_amerzeidan) 's Twitter Profile Photo

Honoring two giants in #MDSsm at the #MDSF25 MDS Foundation biennial meeting in Rotterdam with life achievement awards to Dr John Bennett (who just turned 91) & Dr Peter Greenberg for their life long immense contributions to the field. We truly stand on the shoulders of giants!

Honoring two giants in #MDSsm at the #MDSF25 <a href="/MDSFoundation/">MDS Foundation</a> biennial meeting in Rotterdam with life achievement awards to Dr John Bennett (who just turned 91) &amp; Dr Peter Greenberg for their life long immense contributions to the field. We truly stand on the shoulders of giants!
Yazan Madanat, MD (@madanatyazan) 's Twitter Profile Photo

#LifetimeAchievementAward — Humbled to witness two legends, Drs. John Bennett and Peter Greenberg, accept this well-deserved honor. #Remarkable moment led by Stephen D. Nimer, MD — celebrating their lasting impact on MDS. What a way to close the morning session #MDS25 MDS Foundation

#LifetimeAchievementAward — Humbled to witness two legends, Drs. John Bennett and Peter Greenberg, accept this well-deserved honor. #Remarkable moment led by <a href="/DrSDNimer/">Stephen D. Nimer, MD</a> — celebrating their lasting impact on MDS. What a way to close the morning session #MDS25 <a href="/MDSFoundation/">MDS Foundation</a>
Sanam Loghavi, MD صنم لغوی 🔬🧬 (@sanamloghavi) 's Twitter Profile Photo

BLAST: A Globally Applicable and Molecularly Versatile Survival Model for Chronic Myelomonocytic Leukemia | Blood | American Society of Hematology ⁦Blood Journal⁩ ⁦Mrinal Patnaik⁩ ⁦Guillermo Montalban-Bravo⁩ #CMML #hemepath ashpublications.org/blood/article/…

Yazan Madanat, MD (@madanatyazan) 's Twitter Profile Photo

Fantastic talk by Amer Zeidan MBBS,MHS ‏عامر زيدان Yale Cancer Center at #MDS25 MDS Foundation, using '#BoulevardofBrokenDreams' to describe the challenges in higher-risk MDS drug development. #The18thInternationalCongress on #MDS youtu.be/Soa3gO7tL-c?si…

Fantastic talk by <a href="/Dr_AmerZeidan/">Amer Zeidan MBBS,MHS ‏عامر زيدان</a> <a href="/YaleCancer/">Yale Cancer Center</a> at #MDS25 <a href="/MDSFoundation/">MDS Foundation</a>, using '#BoulevardofBrokenDreams' to 
 describe the challenges in higher-risk MDS drug development. #The18thInternationalCongress on #MDS youtu.be/Soa3gO7tL-c?si…
UTSW Hematology & Oncology (@utswhemeonc) 's Twitter Profile Photo

🎉 Congratulations to Professor James Brugarolas , founding director of the UTSW-Kidney Cancer Program, on his election to the Association of American Physicians (AAP)!

🎉 Congratulations to Professor <a href="/JBrugarolas/">James Brugarolas</a> , founding director of the UTSW-Kidney Cancer Program, on his election to the Association of American Physicians (AAP)!
Yazan Madanat, MD (@madanatyazan) 's Twitter Profile Photo

Plenary #5 at #MDS25 in #Rotterdam: Drs. Ulrich Germing, Rob Hasserjian & Amer Zeidan MBBS,MHS ‏عامر زيدان delivered a thoughtful and forward-looking update on the 2025 WHO/ICC classification. There’s a light at the end of the tunnel—and it’s molecularly informed. 💡🧬 MDS Foundation Visit Netherlands

Plenary #5 at #MDS25 in #Rotterdam: Drs. Ulrich Germing, Rob Hasserjian &amp; <a href="/Dr_AmerZeidan/">Amer Zeidan MBBS,MHS ‏عامر زيدان</a> delivered a thoughtful and forward-looking update on the 2025 WHO/ICC classification. There’s a light at the end of the tunnel—and it’s molecularly informed. 💡🧬 <a href="/MDSFoundation/">MDS Foundation</a> <a href="/Visit_NL/">Visit Netherlands</a>
UTSW Simmons Cancer Center (@utswcancer) 's Twitter Profile Photo

Join us for a live webinar with Vivian Irizarry Gatell, M.D., as she discusses the unique and comprehensive treatments, multi-faceted support, and survivorship resources that younger patients need, why it’s important, and how we can help. Register here: bit.ly/4keHJeG.

Join us for a live webinar with Vivian Irizarry Gatell, M.D., as she discusses the unique and comprehensive treatments, multi-faceted support, and survivorship resources that younger patients need, why it’s important, and how we can help. 

Register here: bit.ly/4keHJeG.
Hagop Kantarjian,MD (@drhkantarjian) 's Twitter Profile Photo

New in Leukemia Journal : Outcomes in intensively treated KMT2Ar #AML have improved over time. But low-intensity therapies still show poor results — highlighting the urgent need to explore menin inhibitors nature.com/articles/s4137… #leusm

New in <a href="/LeukemiaJnl/">Leukemia Journal</a> : Outcomes in intensively treated KMT2Ar #AML have improved over time. But low-intensity therapies still show poor results — highlighting the urgent need to explore menin inhibitors
nature.com/articles/s4137…
#leusm
Carmelo Gurnari (@carmelogurnari) 's Twitter Profile Photo

Finally out: how to deal with anemia in #VEXAS?? #MDS therapy helps us! Check the Italian 🇮🇹 experience onlinelibrary.wiley.com/doi/pdfdirect/…

Finally out: how to deal with anemia in #VEXAS?? #MDS therapy helps us! Check the Italian 🇮🇹 experience onlinelibrary.wiley.com/doi/pdfdirect/…
Curtis Lachowiez (@clachowiez) 's Twitter Profile Photo

Our new publication is out today in the OnlineFirst section of Blood Cancer Discovery! We explored correlations between monocytic AML, genetics, and survival by leveraging a large international clinical cohort of patients with AML treated with HMA+VEN. aacrjournals.org/bloodcancerdis…

Joshua Zeidner MD (@leukdocjz) 's Twitter Profile Photo

Hot off the press! Our GEN-PHEN-VEN study led by Curtis Lachowiez showing the importance of phenotype for risk class. of AML Tx w/ Aza/Ven. Monocytic diff. associated w/ worse outcomes and should be part of our risk class. Glad to be part of this impactful analysis UNC Lineberger